Granite Point Capital Management, L.P. - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 51 filers reported holding OVID THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,445,000
+28.1%
348,2630.0%0.23%
+27.7%
Q3 2019$1,128,000
+45.9%
348,263
-16.7%
0.18%
+240.4%
Q2 2019$773,000
+4.5%
417,8570.0%0.05%
-27.8%
Q1 2019$740,000
+16.7%
417,857
+273.7%
0.07%
+71.4%
Q3 2018$634,000
-70.9%
111,826
-59.9%
0.04%
-78.5%
Q2 2018$2,177,000
+2431.4%
279,040
+2187.2%
0.20%
+2337.5%
Q1 2018$86,000
-41.9%
12,200
-18.7%
0.01%
-42.9%
Q4 2017$148,00015,0000.01%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,000,000$7,820,0004.09%
BVF INC/IL 6,631,051$25,927,0000.97%
EcoR1 Capital, LLC 6,082,200$23,781,0000.89%
GLOBEFLEX CAPITAL L P 1,009,125$3,946,0000.71%
Ikarian Capital, LLC 1,124,872$4,398,0000.36%
CHI Advisors LLC 218,510$854,0000.20%
Artal Group S.A. 2,500,000$9,775,0000.20%
DCF Advisers, LLC 139,701$546,0000.19%
Tibra Equities Europe Ltd 78,700$308,0000.10%
XTX Topco Ltd 50,569$198,0000.07%
View complete list of OVID THERAPEUTICS INC shareholders